Literature DB >> 6771799

Plasma concentrations of alpha-melanotropin in the rat during the acquisition and extinction of conditioned avoidance behaviour and during the acquisition of maze learning behaviour.

J F Wilson, M A Morgan.   

Abstract

Concentrations of immunoassayable alpha-melanotropin in plasma were increased above control levels during the acquisition of conditioned avoidance behaviour but not during the extinction of this behaviour. There were no significant variations in levels of alpha-melanotropin in plasma during the acquisition of reward motivated maze learning behaviour. Throughout the latter test hormone concentrations were increased above normal levels. Non-specific stress was thought to be an important factor in the production of increases in concentrations of alpha-melanotropin in plasma. Acute physical stress, such as that caused by the electric foot shock of the avoidance studies, produced the greatest increases, while the smaller increase noted during maze learning was attributed to the stress of the chronic food deprivation schedule used in this test. The data did not support a role for systemic melanotropin in the processes of learning and memory as there were no consistent correlations between levels of alpha-melanotropin in plasma and the parameters of learning in the tests. Although a role for stress-induced alpha-melanotropin release from the pituitary gland in the enhancement of attention was thought possible, actions of exogenous melanotropins on behaviour could be due to effects on melanotropin-containing systems present within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771799     DOI: 10.1007/bf00426652

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Effect of intravenous and intracarotid injections of hypertonic fluids on the release of melanocyte-stimulating hormone from the rat posterior pituitary lobe incubated in situ.

Authors:  A Cyrkowicz; W Z Traczyk
Journal:  J Endocrinol       Date:  1975-07       Impact factor: 4.286

Review 2.  Peptides and behavior.

Authors:  D de Wied
Journal:  Life Sci       Date:  1977-01-15       Impact factor: 5.037

3.  Effect of cold exposure on alpha-MSH and ACTH release in the rat.

Authors:  R Usategui; P Gillioz; C Oliver
Journal:  Horm Metab Res       Date:  1977-11       Impact factor: 2.936

4.  Cyclical changes in concentrations of alpha-melanotrophin in the plasma of male and female rats.

Authors:  J F Wilson; M A Morgan
Journal:  J Endocrinol       Date:  1979-09       Impact factor: 4.286

5.  Immunoreactive alpha-MSH and ACTH levels in rat plasma and pituitary.

Authors:  R Usategui; C Oliver; H Vaudry; G Lombardi; I Rozenberg; A M Mourre
Journal:  Endocrinology       Date:  1976-01       Impact factor: 4.736

6.  Enhancement of attention in man with ACTH/MSH 4-10.

Authors:  C A Sandman; J M George; J D Nolan; H van Riezen; A J Kastin
Journal:  Physiol Behav       Date:  1975-10

7.  Localization of alpha-melanocyte-stimulating hormone in rat brain and pituitary.

Authors:  D Dubé; J C Lissitzky; R Leclerc; G Pelletier
Journal:  Endocrinology       Date:  1978-04       Impact factor: 4.736

8.  Circadian variation in plasma melanocyte stimulating hormone activity in the rat.

Authors:  J D Dunn; A J Kastin; A J Carrillo
Journal:  Int J Chronobiol       Date:  1977

9.  A diurnal rhythm in melanocyte-stimulating hormone content of the rat pituitary gland and its independence from the pineal gland.

Authors:  F J Tilders; P G Smelik
Journal:  Neuroendocrinology       Date:  1975       Impact factor: 4.914

10.  Levels of alpha-melanotrophin in the plasma and pituitary glands of fetal and juvenile rats, and in the plasma of adult female rats during pregnancy and lactation.

Authors:  J F Wilson; M A Morgan
Journal:  J Endocrinol       Date:  1980-03       Impact factor: 4.286

View more
  1 in total

1.  A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma.

Authors:  D R Bard; C G Knight; D P Page-Thomas
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.